The original belief that genes are predominantly protein coding has been disproven with the relatively recent discovery of new classes of regulatory non-coding RNAs. One such class of non-coding RNAs is the long non-coding RNAs (lncRNAs). Recent cell-based studies have demonstrated the potential for lncRNAs to regulate innate immune responses, however, their effect upon immune tolerance in vivo has not been characterised. We have identified a novel gene for which sequence variation is associated with autoimmune diabetes in the nonobese diabetic (NOD) mouse strain. Bioinformatics and expression analyses indicate this gene encodes a lncRNA that is induced by toll-like receptor (TLR) activation and localizes to the nucleus and cytoplasm of dendritic cells. Moreover, sequence variation for this gene is associated with altered TLR-mediated cytokine production. Hence this gene was named Apics for Attenuator of Pattern recognition receptor-Induced Cytokine Secretion. To further investigate the function of this lncRNA, we established a C57BL/6 (B6) knockout mouse strain for Apics and found that Apics-deficient dendritic cells exhibit enhanced TLR-mediated cytokine production. Apics-deficient mice also demonstrate increased susceptibility to induced models of autoimmune disease. Our study suggests that lncRNAs, such as Apics, can serve as TLR-inducible repressors that attenuate the magnitude of innate immune responses to reduce the risk for developing autoimmune disease.